GlassScriptPhysician profile
Margaret E Williams-Baker
NPI 1699021063
$2,183.31
in general payments reported to CMS, 2019-2025
12 companies · $831 in 2025
The $831 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $330 · 2023: $504 · 2024: $519 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,853.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $548.78 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $319.35 | 2022-2025 | Austedo Xr, Austedo, Austedo Xr |
| Neurocrine Biosciences, INC. | $304.24 | 2023-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $219.53 | 2022-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $198.74 | 2023-2025 | Spravato |
| Alkermes, INC. | $154.04 | 2022-2025 | Aristada, Vivitrol, Lybalvi |
| Lundbeck LLC | $142.62 | 2022-2025 | Rexulti |
| Axsome Therapeutics, INC. | $120.77 | 2023-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $61.53 | 2022-2024 | Rexulti |
| Sunovion Pharmaceuticals INC. | $52.18 | 2022 | |
| Almatica Pharma LLC | $46.96 | 2022-2025 | Loreev Xr, Sertraline Hcl |
| Braeburn INC. | $14.57 | 2024 | Brixadi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Williams-Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.